Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Wacker

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
ACS Central Science|September 2, 2024
Can Targeting the Sodium Site via Water Molecules Lead to the Development of Safer Opioids?Daniel Wacker, Marta Filizola
Biochemistry|April 24, 2020
A Novel Cryo-EM Structure Enables Development of Selective Cannabinoid Receptor DrugsGregory Zilberg, Daniel Wacker
Annual Review of Pharmacology and Toxicology|August 12, 2025
Biased Signaling in Psychedelic ActionDaniel Wacker, John D McCorvy
Nature|June 28, 2018
How the ubiquitous GPCR receptor family selectively activates signalling pathwaysMichael J Capper, Daniel Wacker
Nature Structural & Molecular Biology|April 6, 2016
An alerting structure: human orexin receptor 1Daniel Wacker, Bryan L Roth
Cell|July 29, 2017
How Ligands Illuminate GPCR Molecular PharmacologyDaniel Wacker, Raymond C Stevens, Bryan L Roth
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 11, 2014
Femtosecond crystallography of membrane proteins in the lipidic cubic phaseWei Liu, Daniel Wacker, Chong Wang, et al.
The Journal of Biological Chemistry|August 20, 2023
Molecular insights into GPCR mechanisms for drugs of abuseOmar B Sanchez-Reyes, Gregory Zilberg, John D McCorvy, et al.
Nature Communications|January 3, 2024
Molecular basis of human trace amine-associated receptor 1 activationGregory Zilberg, Alexandra K Parpounas, Audrey L Warren, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Molecular Basis of Human Trace Amine-Associated Receptor 1 ActivationGregory Zilberg, Alexandra K Parpounas, Audrey L Warren, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
ACS Central Science|September 2, 2024
Can Targeting the Sodium Site via Water Molecules Lead to the Development of Safer Opioids?Daniel Wacker, Marta Filizola
Biochemistry|April 24, 2020
A Novel Cryo-EM Structure Enables Development of Selective Cannabinoid Receptor DrugsGregory Zilberg, Daniel Wacker
Annual Review of Pharmacology and Toxicology|August 12, 2025
Biased Signaling in Psychedelic ActionDaniel Wacker, John D McCorvy
Nature|June 28, 2018
How the ubiquitous GPCR receptor family selectively activates signalling pathwaysMichael J Capper, Daniel Wacker
Nature Structural & Molecular Biology|April 6, 2016
An alerting structure: human orexin receptor 1Daniel Wacker, Bryan L Roth
Cell|July 29, 2017
How Ligands Illuminate GPCR Molecular PharmacologyDaniel Wacker, Raymond C Stevens, Bryan L Roth
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 11, 2014
Femtosecond crystallography of membrane proteins in the lipidic cubic phaseWei Liu, Daniel Wacker, Chong Wang, et al.
The Journal of Biological Chemistry|August 20, 2023
Molecular insights into GPCR mechanisms for drugs of abuseOmar B Sanchez-Reyes, Gregory Zilberg, John D McCorvy, et al.
Nature Communications|January 3, 2024
Molecular basis of human trace amine-associated receptor 1 activationGregory Zilberg, Alexandra K Parpounas, Audrey L Warren, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Molecular Basis of Human Trace Amine-Associated Receptor 1 ActivationGregory Zilberg, Alexandra K Parpounas, Audrey L Warren, et al.
Pageof 5